Skip to content

Clinical Application of Neuromuscular Electrical Stimulation Technology Based on Multimodal Physiological Parameter Perception

Clinical Application of Neuromuscular Electrical Stimulation Technology Based on Multimodal Physiological Parameter Perception

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115297
Enrollment
Unknown
Registered
2025-12-24
Start date
2025-07-20
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral stroke

Interventions

EMG triggered NMES treatment group:On the basis of routine rehabilitation treatment, NMES triggered by EMG (surface EMG analysis feedback instrument, Shaoxing United Medical Devices Co., Ltd., UMI-SE-
NMES treatment group triggered by EEG:On the basis of routine rehabilitation treatment, NMES treatment triggered by EEG (EEG acquisition and rehabilitation training equipment, Xiangtan Mailian Medical

Sponsors

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. 18 to 75 years old (inclusive). 2. The first stroke patients hospitalized in the department of rehabilitation medicine whose onset is within 6 months. 3. It conforms to the diagnostic criteria of stroke adopted by the 4th National Conference on Cerebrovascular Diseases. 4. Unilateral cerebral hemisphere lesions, which were definitely diagnosed by head CT or MRI. 5. Stable vital signs, clear consciousness, MMSE score >=24, and acceptable action instructions. 6. Brunnstrom stage of the affected upper limb is less than or equal to stage <=III, and the muscle tension MAS grade is less than grade 2. 7. Volunteer to participate in this study and sign the informed consent form. If the subject is unable to read and/or sign the informed consent due to incapacity and other reasons, his guardian is required to represent the informed process and sign the informed consent. If the subjects are unable to read the informed consent form (such as illiterate subjects), witnesses need to witness the informed process and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. There was a history of mental illness and cerebrovascular disease before onset. 2. Patients with conscious disturbance, aphasia, dementia, intellectual impairment and previous brain organic diseases and cognitive impairment after stroke (MMSE score is less than 23). 3. Cardiogenic cerebral infarction or massive cerebral hemorrhage, transient cerebral ischemia and reversible stroke. 4. Patients with bilateral hemispheric injuries and patients who have undergone brain surgery except minimally invasive interventional embolectomy after stroke. 5. Those whose severe cardiopulmonary complications affect the rehabilitation evaluation and those whose limbs have motor dysfunction left by previous injuries. 6.There are other reasons that researchers think are not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer upper limb score;Brunnstrom Stage;Modified Ashworth Scale;Lovett muscle strength grading;

Secondary

MeasureTime frame
Surface electromyography assessment indicators;

Countries

China

Contacts

Public ContactWu Fangchao

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

3414030@zju.edu.cn+86 158 6714 4366

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026